APO Research
Talk to an analyst

APO RESEARCH · REPORT

Generic Injectables

Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.

Selected research

Market Structure

Global Generic Injectables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchGeneric Injectables Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Injectables Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Generic Injectables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Injectables Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Injectables Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.

In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.

Read the full market overview

Report Includes

This report provides an overview of the global Generic Injectables market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Generic Injectables and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Generic Injectables revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Generic Injectables market size, projected growth trends, production technologies, key applications, and end-use industries.

Generic Injectables Segment by Company

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Generic Injectables Segment by Type

Small Molecule

Large Molecule

Generic Injectables Segment by Application

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

Generic Injectables Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Injectables.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Generic Injectables in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Generic Injectables industry.

Chapter 3: Detailed analysis of Generic Injectables companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Generic Injectablesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Generic Injectables Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Small Molecule Table 3. Key Players of Large Molecule Table 4. Global Generic Injectables Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oncology Table 6. Key Players of Anesthesia Table 7. Key Players of Anti-Infectives Table 8. Key Players of Parenteral Nutrition Table 9. Key Players of Cardiovascular Diseases Table 10. Global Generic Injectables Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Generic Injectables Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Generic Injectables Market Share by Region (2021-2026) Table 13. Global Generic Injectables Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Generic Injectables Market Share by Region (2027-2032) Table 15. Generic Injectables Industry Trends Table 16. Generic Injectables Industry Drivers Table 17. Generic Injectables Industry Opportunities and Challenges Table 18. Generic Injectables Industry Restraints Table 19. Global Generic Injectables Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Generic Injectables Revenue Market Share by Company (2021-2026) Table 21. Global Generic Injectables Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Generic Injectables Key Company Head Office and Area Served Table 23. Global Generic Injectables Company, Product Type & Application Table 24. Global Generic Injectables Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Generic Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Generic Injectables Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Generic Injectables Revenue Market Share by Type (2021-2026) Table 31. Global Generic Injectables Revenue Market Share by Type (2027-2032) Table 32. Global Generic Injectables Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Generic Injectables Revenue Market Share by Application (2021-2026) Table 36. Global Generic Injectables Revenue Market Share by Application (2027-2032) Table 37. Hospira (Pfizer Inc.) Company Information Table 38. Hospira (Pfizer Inc.) Business Overview Table 39. Hospira (Pfizer Inc.) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Hospira (Pfizer Inc.) Generic Injectables Product Portfolio Table 41. Hospira (Pfizer Inc.) Recent Development Table 42. Fresenius Kabi Company Information Table 43. Fresenius Kabi Business Overview Table 44. Fresenius Kabi Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Fresenius Kabi Generic Injectables Product Portfolio Table 46. Fresenius Kabi Recent Development Table 47. Sandoz (Novartis) Company Information Table 48. Sandoz (Novartis) Business Overview Table 49. Sandoz (Novartis) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sandoz (Novartis) Generic Injectables Product Portfolio Table 51. Sandoz (Novartis) Recent Development Table 52. Hikma Pharmaceuticals PLC Company Information Table 53. Hikma Pharmaceuticals PLC Business Overview Table 54. Hikma Pharmaceuticals PLC Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Hikma Pharmaceuticals PLC Generic Injectables Product Portfolio Table 56. Hikma Pharmaceuticals PLC Recent Development Table 57. Dr. Reddy’s Laboratories Ltd Company Information Table 58. Dr. Reddy’s Laboratories Ltd Business Overview Table 59. Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Dr. Reddy’s Laboratories Ltd Generic Injectables Product Portfolio Table 61. Dr. Reddy’s Laboratories Ltd Recent Development Table 62. Grifols Company Information Table 63. Grifols Business Overview Table 64. Grifols Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Grifols Generic Injectables Product Portfolio Table 66. Grifols Recent Development Table 67. Nichi-Iko Group (Sagent) Company Information Table 68. Nichi-Iko Group (Sagent) Business Overview Table 69. Nichi-Iko Group (Sagent) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Nichi-Iko Group (Sagent) Generic Injectables Product Portfolio Table 71. Nichi-Iko Group (Sagent) Recent Development Table 72. Teva Pharmaceutical Company Information Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Teva Pharmaceutical Generic Injectables Product Portfolio Table 76. Teva Pharmaceutical Recent Development Table 77. Auromedics Company Information Table 78. Auromedics Business Overview Table 79. Auromedics Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Auromedics Generic Injectables Product Portfolio Table 81. Auromedics Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Sanofi Generic Injectables Product Portfolio Table 86. Sanofi Recent Development Table 87. Gland Pharma Company Information Table 88. Gland Pharma Business Overview Table 89. Gland Pharma Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Gland Pharma Generic Injectables Product Portfolio Table 91. Gland Pharma Recent Development Table 92. Endo International PLC Company Information Table 93. Endo International PLC Business Overview Table 94. Endo International PLC Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Endo International PLC Generic Injectables Product Portfolio Table 96. Endo International PLC Recent Development Table 97. North America Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Generic Injectables Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Generic Injectables Market Size by Country (2021-2026) Table 103. North America Generic Injectables Market Size by Country (2027-2032) Table 104. Europe Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Generic Injectables Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Generic Injectables Market Size by Country (2021-2026) Table 110. Europe Generic Injectables Market Size by Country (2027-2032) Table 111. China Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 112. China Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 113. China Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 114. China Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Generic Injectables Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Generic Injectables Market Size by Country (2021-2026) Table 121. Asia Generic Injectables Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Generic Injectables Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Generic Injectables Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Generic Injectables Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Generic Injectables Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Generic Injectables Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Generic Injectables Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Generic Injectables Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Generic Injectables Product Image Figure 2. Global Generic Injectables Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Generic Injectables Market Share by Type: 2025 VS 2032 Figure 4. Small Molecule Image Figure 5. Large Molecule Image Figure 6. Global Generic Injectables Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Generic Injectables Market Share by Application: 2025 VS 2032 Figure 8. Oncology Image Figure 9. Anesthesia Image Figure 10. Anti-Infectives Image Figure 11. Parenteral Nutrition Image Figure 12. Cardiovascular Diseases Image Figure 13. Global Generic Injectables Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 15. Global Generic Injectables Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Generic Injectables Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Generic Injectables Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Generic Injectables Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Generic Injectables Revenue Market Share by Type (2021-2032) Figure 22. Global Generic Injectables Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Generic Injectables Revenue Market Share by Application (2021-2032) Figure 24. North America Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 25. North America Generic Injectables Market Share by Type (2021-2032) Figure 26. North America Generic Injectables Market Share by Application (2021-2032) Figure 27. North America Generic Injectables Market Share by Country (2021-2032) Figure 28. United States Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 29. Canada Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 31. Europe Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 32. Europe Generic Injectables Market Share by Type (2021-2032) Figure 33. Europe Generic Injectables Market Share by Application (2021-2032) Figure 34. Europe Generic Injectables Market Share by Country (2021-2032) Figure 35. Germany Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 36. France Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 38. Italy Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 39. Russia Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 41. China Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 42. China Generic Injectables Market Share by Type (2021-2032) Figure 43. China Generic Injectables Market Share by Application (2021-2032) Figure 44. Asia Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 45. Asia Generic Injectables Market Share by Type (2021-2032) Figure 46. Asia Generic Injectables Market Share by Application (2021-2032) Figure 47. Asia Generic Injectables Market Share by Country (2021-2032) Figure 48. Japan Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 52. India Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 53. Australia Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Generic Injectables Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Generic Injectables Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Generic Injectables Market Share by Country (2021-2032) Figure 58. Brazil Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 63. UAE Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 65. Chile Generic Injectables Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule
  • Large Molecule
Applications
  • Oncology
  • Anesthesia
  • Anti-Infectives
  • Parenteral Nutrition
  • Cardiovascular Diseases
Companies covered
  • Hospira (Pfizer Inc.)
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy’s Laboratories Ltd
  • Grifols
  • Nichi-Iko Group (Sagent)
  • Teva Pharmaceutical
  • Auromedics
  • Sanofi
  • Gland Pharma
  • Endo International PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Generic Injectables Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Small Molecule
  5. 1.2.3 Large Molecule
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Generic Injectables Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Oncology
  9. 1.3.3 Anesthesia
  10. 1.3.4 Anti-Infectives
  11. 1.3.5 Parenteral Nutrition
  12. 1.3.6 Cardiovascular Diseases
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Generic Injectables Growth Trends by Region
  15. 1.5.1 Global Generic Injectables Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Generic Injectables Market Size by Region (2021-2026)
  17. 1.5.3 Generic Injectables Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Generic Injectables Market Dynamics
  1. 2.1 Generic Injectables Industry Trends
  2. 2.2 Generic Injectables Industry Drivers
  3. 2.3 Generic Injectables Industry Opportunities and Challenges
  4. 2.4 Generic Injectables Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Generic Injectables Revenue by Company (2021-2026)
  2. 3.2 Global Generic Injectables Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Generic Injectables Key Company Head office and Area Served
  4. 3.4 Global Generic Injectables Company, Product Type & Application
  5. 3.5 Global Generic Injectables Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Generic Injectables Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Generic Injectables Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Generic Injectables Tier 1, Tier 2, and Tier 3
4 Generic Injectables Market by Type
  1. 4.1 Global Generic Injectables Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Generic Injectables Market Size by Type (2021-2032)
  3. 4.3 Global Generic Injectables Market Size Share by Type (2021-2032)
5 Generic Injectables Market by Application
  1. 5.1 Global Generic Injectables Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Generic Injectables Market Size by Application (2021-2032)
  3. 5.3 Global Generic Injectables Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hospira (Pfizer Inc.)
  2. 6.1.1 Hospira (Pfizer Inc.) Company Information
  3. 6.1.2 Hospira (Pfizer Inc.) Business Overview
  4. 6.1.3 Hospira (Pfizer Inc.) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Hospira (Pfizer Inc.) Generic Injectables Product Portfolio
  6. 6.1.5 Hospira (Pfizer Inc.) Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Fresenius Kabi Generic Injectables Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Sandoz (Novartis)
  14. 6.3.1 Sandoz (Novartis) Company Information
  15. 6.3.2 Sandoz (Novartis) Business Overview
  16. 6.3.3 Sandoz (Novartis) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sandoz (Novartis) Generic Injectables Product Portfolio
  18. 6.3.5 Sandoz (Novartis) Recent Developments
  19. 6.4 Hikma Pharmaceuticals PLC
  20. 6.4.1 Hikma Pharmaceuticals PLC Company Information
  21. 6.4.2 Hikma Pharmaceuticals PLC Business Overview
  22. 6.4.3 Hikma Pharmaceuticals PLC Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Hikma Pharmaceuticals PLC Generic Injectables Product Portfolio
  24. 6.4.5 Hikma Pharmaceuticals PLC Recent Developments
  25. 6.5 Dr. Reddy’s Laboratories Ltd
  26. 6.5.1 Dr. Reddy’s Laboratories Ltd Company Information
  27. 6.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
  28. 6.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Dr. Reddy’s Laboratories Ltd Generic Injectables Product Portfolio
  30. 6.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments
  31. 6.6 Grifols
  32. 6.6.1 Grifols Company Information
  33. 6.6.2 Grifols Business Overview
  34. 6.6.3 Grifols Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Grifols Generic Injectables Product Portfolio
  36. 6.6.5 Grifols Recent Developments
  37. 6.7 Nichi-Iko Group (Sagent)
  38. 6.7.1 Nichi-Iko Group (Sagent) Company Information
  39. 6.7.2 Nichi-Iko Group (Sagent) Business Overview
  40. 6.7.3 Nichi-Iko Group (Sagent) Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nichi-Iko Group (Sagent) Generic Injectables Product Portfolio
  42. 6.7.5 Nichi-Iko Group (Sagent) Recent Developments
  43. 6.8 Teva Pharmaceutical
  44. 6.8.1 Teva Pharmaceutical Company Information
  45. 6.8.2 Teva Pharmaceutical Business Overview
  46. 6.8.3 Teva Pharmaceutical Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Generic Injectables Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Recent Developments
  49. 6.9 Auromedics
  50. 6.9.1 Auromedics Company Information
  51. 6.9.2 Auromedics Business Overview
  52. 6.9.3 Auromedics Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Auromedics Generic Injectables Product Portfolio
  54. 6.9.5 Auromedics Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sanofi Generic Injectables Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Gland Pharma
  62. 6.11.1 Gland Pharma Company Information
  63. 6.11.2 Gland Pharma Business Overview
  64. 6.11.3 Gland Pharma Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Gland Pharma Generic Injectables Product Portfolio
  66. 6.11.5 Gland Pharma Recent Developments
  67. 6.12 Endo International PLC
  68. 6.12.1 Endo International PLC Company Information
  69. 6.12.2 Endo International PLC Business Overview
  70. 6.12.3 Endo International PLC Generic Injectables Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Endo International PLC Generic Injectables Product Portfolio
  72. 6.12.5 Endo International PLC Recent Developments
7 North America
  1. 7.1 North America Generic Injectables Market Size (2021-2032)
  2. 7.2 North America Generic Injectables Market Size by Type
  3. 7.2.1 North America Generic Injectables Market Size by Type (2021-2026)
  4. 7.2.2 North America Generic Injectables Market Size by Type (2027-2032)
  5. 7.2.3 North America Generic Injectables Market Share by Type (2021-2032)
  6. 7.3 North America Generic Injectables Market Size by Application
  7. 7.3.1 North America Generic Injectables Market Size by Application (2021-2026)
  8. 7.3.2 North America Generic Injectables Market Size by Application (2027-2032)
  9. 7.3.3 North America Generic Injectables Market Share by Application (2021-2032)
  10. 7.4 North America Generic Injectables Market Size by Country
  11. 7.4.1 North America Generic Injectables Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Generic Injectables Market Size by Country (2021-2026)
  13. 7.4.3 North America Generic Injectables Market Size by Country (2027-2032)
  14. 7.4.4 North America Generic Injectables Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Generic Injectables Market Size (2021-2032)
  2. 8.2 Europe Generic Injectables Market Size by Type
  3. 8.2.1 Europe Generic Injectables Market Size by Type (2021-2026)
  4. 8.2.2 Europe Generic Injectables Market Size by Type (2027-2032)
  5. 8.2.3 Europe Generic Injectables Market Share by Type (2021-2032)
  6. 8.3 Europe Generic Injectables Market Size by Application
  7. 8.3.1 Europe Generic Injectables Market Size by Application (2021-2026)
  8. 8.3.2 Europe Generic Injectables Market Size by Application (2027-2032)
  9. 8.3.3 Europe Generic Injectables Market Share by Application (2021-2032)
  10. 8.4 Europe Generic Injectables Market Size by Country
  11. 8.4.1 Europe Generic Injectables Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Generic Injectables Market Size by Country (2021-2026)
  13. 8.4.3 Europe Generic Injectables Market Size by Country (2027-2032)
  14. 8.4.4 Europe Generic Injectables Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Generic Injectables Market Size (2021-2032)
  2. 9.2 China Generic Injectables Market Size by Type
  3. 9.2.1 China Generic Injectables Market Size by Type (2021-2026)
  4. 9.2.2 China Generic Injectables Market Size by Type (2027-2032)
  5. 9.2.3 China Generic Injectables Market Share by Type (2021-2032)
  6. 9.3 China Generic Injectables Market Size by Application
  7. 9.3.1 China Generic Injectables Market Size by Application (2021-2026)
  8. 9.3.2 China Generic Injectables Market Size by Application (2027-2032)
  9. 9.3.3 China Generic Injectables Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Generic Injectables Market Size (2021-2032)
  2. 10.2 Asia Generic Injectables Market Size by Type
  3. 10.2.1 Asia Generic Injectables Market Size by Type (2021-2026)
  4. 10.2.2 Asia Generic Injectables Market Size by Type (2027-2032)
  5. 10.2.3 Asia Generic Injectables Market Share by Type (2021-2032)
  6. 10.3 Asia Generic Injectables Market Size by Application
  7. 10.3.1 Asia Generic Injectables Market Size by Application (2021-2026)
  8. 10.3.2 Asia Generic Injectables Market Size by Application (2027-2032)
  9. 10.3.3 Asia Generic Injectables Market Share by Application (2021-2032)
  10. 10.4 Asia Generic Injectables Market Size by Country
  11. 10.4.1 Asia Generic Injectables Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Generic Injectables Market Size by Country (2021-2026)
  13. 10.4.3 Asia Generic Injectables Market Size by Country (2027-2032)
  14. 10.4.4 Asia Generic Injectables Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Generic Injectables Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Generic Injectables Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Generic Injectables Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Generic Injectables Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Generic Injectables Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Generic Injectables Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Generic Injectables Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Generic Injectables Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Generic Injectables Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Generic Injectables Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Generic Injectables Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Generic Injectables Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Generic Injectables Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Generic Injectables Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst